Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation study
出版年份 2022 全文链接
标题
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation study
作者
关键词
-
出版物
DIABETOLOGIA
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-07-29
DOI
10.1007/s00125-022-05743-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study
- (2022) Haiyan Cheng et al. DIABETES CARE
- Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism?
- (2021) Andrea Giaccari et al. DIABETES CARE
- Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
- (2021) Geert Jan Biessels et al. DIABETOLOGIA
- Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial
- (2021) Daniel K Burns et al. LANCET NEUROLOGY
- The trans-ancestral genomic architecture of glycemic traits
- (2021) Ji Chen et al. NATURE GENETICS
- Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression
- (2021) Urmo Võsa et al. NATURE GENETICS
- Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization
- (2021) Veronika W. Skrivankova et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Is Type 2 Diabetes Mellitus Causally Associated with Cancer Risk? Evidence From a Two-Sample Mendelian Randomisation Study
- (2020) Shuai Yuan et al. DIABETES
- Evaluating the impact of AMPK activation, a target of metformin, on risk of cardiovascular diseases and cancer in the UK Biobank: a Mendelian randomisation study
- (2020) Shan Luo et al. DIABETOLOGIA
- Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial
- (2020) Tali Cukierman-Yaffe et al. LANCET NEUROLOGY
- Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study
- (2020) Katherine Samaras et al. DIABETES CARE
- Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases
- (2020) Jie Zheng et al. NATURE GENETICS
- Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
- (2019) Iris E. Jansen et al. NATURE GENETICS
- Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses
- (2019) Yi-Qian Sun et al. BMJ-British Medical Journal
- The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study
- (2019) Shiu Lun Au Yeung et al. DIABETOLOGIA
- BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
- (2019) Nour M. Moussa‐Pacha et al. MEDICINAL RESEARCH REVIEWS
- Mendelian randomization study showed no causality between metformin use and lung cancer risk
- (2019) Huaqiang Zhou et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Large-scale GWAS reveals genetic architecture of brain white matter microstructure and genetic overlap with cognitive and mental health traits (n = 17,706)
- (2019) Bingxin Zhao et al. MOLECULAR PSYCHIATRY
- The Impact of Glycated Hemoglobin (HbA1c) on Cardiovascular Disease Risk: A Mendelian Randomization Study Using UK Biobank
- (2018) Shiu Lun Au Yeung et al. DIABETES CARE
- Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function
- (2018) Gail Davies et al. Nature Communications
- The MR-Base platform supports systematic causal inference across the human phenome
- (2018) Gibran Hemani et al. eLife
- Aging as a Biological Target for Prevention and Therapy
- (2018) Nir Barzilai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
- (2018) Jared M. Campbell et al. JOURNAL OF ALZHEIMERS DISEASE
- Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
- (2018) Lulu Sun et al. NATURE MEDICINE
- ChEMBL: towards direct deposition of bioassay data
- (2018) David Mendez et al. NUCLEIC ACIDS RESEARCH
- Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption
- (2017) Fernando Pires Hartwig et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Growth Differentiation Factor 15 as a Novel Biomarker for Metformin
- (2016) Hertzel C. Gerstein et al. DIABETES CARE
- Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
- (2016) Jack Bowden et al. GENETIC EPIDEMIOLOGY
- Antihypertensive Drugs, Prevention of Cognitive Decline and Dementia: A Systematic Review of Observational Studies, Randomized Controlled Trials and Meta-Analyses, with Discussion of Potential Mechanisms
- (2015) Laure Rouch et al. CNS DRUGS
- Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
- (2015) J. Bowden et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- The support of human genetic evidence for approved drug indications
- (2015) Matthew R Nelson et al. NATURE GENETICS
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
- (2014) Claudia Giambartolomei et al. PLoS Genetics
- Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease
- (2012) Caroline L Relton et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Avoiding bias from weak instruments in Mendelian randomization studies
- (2011) Stephen Burgess et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now